Literature DB >> 25333792

Determination of SUMO1 and ATP affinity for the SUMO E1by quantitative FRET technology.

Hilda Wiryawan1, Kevin Dan, Myra Etuale, Yali Shen, Jiayu Liao.   

Abstract

SUMOylation plays important roles in many key physiological and pathological processes. The SUMOylation cascade involves a heterodimer of activating enzyme, E1 (Aos1/Uba2); a conjugating enzyme, E2 (Ubc9); and many ligase enzymes, E3. Focusing on the activation step of the SUMOylation process, we examined the interaction of E1 with its substrates. Previous studies reported the Km of E1 enzymes in ubiquitin and other ubiquitin-like pathways, but the Km of the SUMO paralogs (SUMO2 and SUMO3) is unknown. Here, by using quantitative FRET to measure the SUMO E1 enzyme kinetics of SUMO1, 2, and 3 and ATP under steady state conditions, we found that the enzyme kinetics from the quantitative FRET method are comparable to those from conventional radioactive assays. Additionally, the kinetic constants, Km , of SUMO2 (3.418 ± 0.9131 μM) and SUMO3 (2.764 ± 0.75 μM) [FW1] are approximately four to five times higher than that of SUMO1 Km (0.7458 ± 0.1105 μM). These results demonstrate the advantages of FRET technology for determining Km , including the ability to monitor reaction progress in real-time with high-throughput and high-sensitivity in an environmentally friendly manner. The processes discussed here extend the utility of quantitative FRET in characterizing protein-protein interactions and enzyme kinetics.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  SUMOylation; enzyme kinetics; molecular engineering; quantitative FRET assay; systems biology

Mesh:

Substances:

Year:  2015        PMID: 25333792     DOI: 10.1002/bit.25480

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  2 in total

1.  An in vitro Förster resonance energy transfer-based high-throughput screening assay identifies inhibitors of SUMOylation E2 Ubc9.

Authors:  Yu-Zhe Wang; Xiao Liu; George Way; Vipul Madarha; Qing-Tong Zhou; De-Hua Yang; Jia-Yu Liao; Ming-Wei Wang
Journal:  Acta Pharmacol Sin       Date:  2020-04-27       Impact factor: 7.169

2.  The ubiquitin-like modifier FAT10 interferes with SUMO activation.

Authors:  Annette Aichem; Carolin Sailer; Stella Ryu; Nicola Catone; Nicolas Stankovic-Valentin; Gunter Schmidtke; Frauke Melchior; Florian Stengel; Marcus Groettrup
Journal:  Nat Commun       Date:  2019-10-01       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.